Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Stakeholders

2. Research & Forecasting

• 2.1. Research Methodology
  • 2.1.1. Research Instruments
    • 2.1.1.1. Secondary Instrument
    • 2.1.1.2. Primary Instrument
  • 2.1.2. Research Approaches
    • 2.1.2.1. Bottom-up Approach
    • 2.1.2.2. Top-down Approach
  • 2.1.3. Research Reliability & Validity
  • 2.1.4. Research Assumptions
  • 2.1.5. Vendor Inclusion Criteria
• 2.2. Forecasting Methodology
  • 2.2.1. Methodology for Market Estimation & Forecasting
  • 2.2.2. Significance and Importance of the Market Estimation & Forecasting

3. Executive Summary

4. Premium Insight

• 4.1. Market Connectivity
• 4.2. Market Data Feed
• 4.3. Market Vendor Ranking Analysis
• 4.4. Market Dynamics
  • 4.4.1. Drivers
    • 4.4.1.1. Increasing demand for specialty drugs to treat complex or serious chronic conditions
    • 4.4.1.2. Increased reimbursement through the medical benefit, and pharmacy benefit
    • 4.4.1.3. Specialty pharmacy providers collaborating with pharma/biotech manufacturers, payers, MCOs and patients
    • 4.4.1.4. Attractive prospects for biopharmaceutical companies from both business and medical innovation perspective
  • 4.4.2. Restraints
    • 4.4.2.1. Cost sharing discourages the use leading to adverse health outcomes
    • 4.4.2.2. Growth in premium costs
  • 4.4.3. Opportunities
    • 4.4.3.1. Retailers involvements in specialty market and several chains operate their own specialty pharmacy divisions
    • 4.4.3.2. Stimulated diagnostic research
    • 4.4.3.3. Vendors offering compliance programs, reimbursement assistance programs and distribution channels
    • 4.4.3.4. Growth of enhanced information technologies in the specialty sector
    • 4.4.3.5. Value-added programs targeting physicians, nurses, patients and caregivers
  • 4.4.4. Challenges
    • 4.4.4.1. Less focus on development of low-cost generic equivalents of specialty drugs
• 4.5. Porter’s Five Forces Analysis
  • 4.5.1. Threat of New Entrants
  • 4.5.2. Threat of Substitutes
  • 4.5.3. Bargaining Power of Customers
  • 4.5.4. Bargaining Power of Suppliers
  • 4.5.5. Industry Rivalry
• 4.6. Regulatory Framework
• 4.7. Value Chain Analysis

5. Global Specialty Pharmaceuticals Market, by Type

• 5.1. Introduction
• 5.2. CNS
• 5.3. Infectious diseases
• 5.4. Momen’s health
• 5.5. Oncology
• 5.6. Respiratory

6. Global Specialty Pharmaceuticals Market, by Distribution Channel

• 6.1. Introduction
• 6.2. Infectious Diseases
• 6.3. Physician Clinics
• 6.4. Retail and specialty pharmacies

7. Global Specialty Pharmaceuticals Market, by Geography

• 7.1. Introduction
• 7.2. Americas Specialty Pharmaceuticals Market
  • 7.2.1. Americas Specialty Pharmaceuticals Market, by Country
    • 7.2.1.1. United States
    • 7.2.1.2. Brazil
    • 7.2.1.3. Canada
    • 7.2.1.4. Mexico
    • 7.2.1.5. Argentina
  • 7.2.2. Americas Specialty Pharmaceuticals Market, by Type
  • 7.2.3. Americas Specialty Pharmaceuticals Market, by Distribution Channel
• 7.3. Europe, Middle East & Africa Specialty Pharmaceuticals Market
  • 7.3.1. Europe, Middle East & Africa Specialty Pharmaceuticals Market, by Country
    • 7.3.1.1. United Kingdom
    • 7.3.1.2. Germany
    • 7.3.1.3. France
    • 7.3.1.4. Saudi Arabia
    • 7.3.1.5. United Arab Emirates
    • 7.3.1.6. Italy
    • 7.3.1.7. Russia
  • 7.3.2. Europe, Middle East & Africa Specialty Pharmaceuticals Market, by Type
  • 7.3.3. Europe, Middle East & Africa Specialty Pharmaceuticals Market, by Distribution Channel
• 7.4. Asia-Pacific Specialty Pharmaceuticals Market
  • 7.4.1. Asia-Pacific Specialty Pharmaceuticals Market, by Country
    • 7.4.1.1. China
    • 7.4.1.2. Japan
    • 7.4.1.3. India
    • 7.4.1.4. Australia
  • 7.4.2. Asia-Pacific Specialty Pharmaceuticals Market, by Type
  • 7.4.3. Asia-Pacific Specialty Pharmaceuticals Market, by Distribution Channel

8. Competitive Strategic Window

• 8.1. Introduction
  • 8.1.1. Leverage Zone
  • 8.1.2. Vantage Zone
  • 8.1.3. Speculative Zone
  • 8.1.4. Bottleneck Zone

9. FPNV Positioning Matrix

• 9.1. Introduction
• 9.2. Scores
  • 9.2.1. Forefront
  • 9.2.2. Pathfinders
  • 9.2.3. Niche
  • 9.2.4. Vital
• 9.3. Business Strategy
• 9.4. Product Satisfaction

10. Competitive News Feed Analysis

11. Company Usability Profiles

• 11.1. Accredo Health Group, Inc.
• 11.2. Avella Specialty Pharmacy, Inc.
• 11.3. CIGNA Pharmacy Management
• 11.4. CVS Health Corporation
• 11.5. Diplomat Pharmacy, Inc.
• 11.6. ENESI
• 11.7. Endo Pharmaceuticals Inc.
• 11.8. Humana Pharmacy, Inc.
• 11.9. Hyphens Pharma Pte Ltd.
• 11.10. Kroger Specialty Pharmacy, Inc.
• 11.11. McKesson Corporation
• 11.12. Midatech Pharma PLC
• 11.13. US WorldMeds, LLC
• 11.14. UnitedHealth Group Incorporated
• 11.15. Walgreens Boots Alliance, Inc.

12. Appendix

• 12.1. Top Reports
• 12.2. Author Details

LIST OF TABLES (28 TABLES)

TABLE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET RANKING, BY VENDORS, 2017

TABLE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)

TABLE 10. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 11. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PHYSICIAN CLINICS, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD BILLION)

TABLE 14. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 15. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 16. AMERICAS SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)

TABLE 17. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 18. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 19. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)

TABLE 20. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)

TABLE 21. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2016 - 2024 (USD BILLION)

TABLE 22. ASIA-PACIFIC SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016 - 2024 (USD BILLION)

TABLE 23. 360IRESEARCH SCORES FOR FOREFRONT IN SPECIALTY PHARMACEUTICALS MARKET

TABLE 24. 360IRESEARCH SCORES FOR PATHFINDERS IN SPECIALTY PHARMACEUTICALS MARKET

TABLE 25. 360IRESEARCH SCORES FOR NICHE IN SPECIALTY PHARMACEUTICALS MARKET

TABLE 26. 360IRESEARCH SCORES FOR VITAL IN SPECIALTY PHARMACEUTICALS MARKET

TABLE 27. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR SPECIALTY PHARMACEUTICALS MARKET

TABLE 28. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR SPECIALTY PHARMACEUTICALS MARKET

LIST OF FIGURES (26 TABLES)

FIGURE 1. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: YEARS CONSIDERED FOR THE STUDY

FIGURE 2. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH METHODOLOGY

FIGURE 3. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH INSTRUMENTS

FIGURE 4. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY SECONDARY INSTRUMENT SOURCES

FIGURE 5. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY POTENTIAL RESPONDENTS

FIGURE 6. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT

FIGURE 7. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH APPROACHES

FIGURE 8. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY DATA TRIANGULATION

FIGURE 9. GLOBAL SPECIALTY PHARMACEUTICALS MARKET: KEY RESEARCH ASSUMPTIONS

FIGURE 10. SPECIALTY PHARMACEUTICALS MARKET: KEY MARKET CONNECTIVITY

FIGURE 11. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, 2016 - 2024 (USD BILLION)

FIGURE 12. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD BILLION)

FIGURE 13. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY CNS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 14. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 15. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY MOMEN’S HEALTH, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 16. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 17. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RESPIRATORY, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 18. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017 VS 2024 (USD BILLION)

FIGURE 19. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 20. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY PHYSICIAN CLINICS, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 21. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY GEOGRAPHY, 2017 VS 2024 (USD BILLION)

FIGURE 22. GLOBAL SPECIALTY PHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2017 (USD BILLION)

FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY TYPE, 2024

FIGURE 24. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024

FIGURE 25. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY PHARMACEUTICALS MARKET, BY GEOGRAPHY, 2024

FIGURE 26. 360IRESEARCH FPNV POSITIONING MATRIX FOR SPECIALTY PHARMACEUTICALS MARKET

The global specialty pharmaceuticals market is expected to grow from USD 138.45 billion 2017 to USD 510.45 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 20.49%.

“Increasing demand for specialty drugs to treat complex or serious chronic conditionsis one of the factors largely attributing to the growth of specialty pharmaceuticals market globally”

The factors attributing to the growth of the market are increasing demand for specialty drugs to treat complex or serious chronic conditions, increased reimbursement through the medical benefit, and pharmacy benefit, specialty pharmacy providers collaborating with pharma/biotech manufacturers, payers, mcos and patients, and attractive prospects for biopharmaceutical companies from both business and medical innovation perspective. However, some factors such as cost sharing discourages the use leading to adverse health outcomes, and growth in premium costs may hinder the market growth. The global specialty pharmaceuticals market is expected to showcase the opportunities such as retailers involvements in specialty market and several chains operate their own specialty pharmacy divisions, stimulated diagnostic research, vendors offering compliance programs, reimbursement assistance programs and distribution channels, growth of enhanced information technologies in the specialty sector, and value-added programs targeting physicians, nurses, patients and caregivers. In the near future, the market may face the possible challenges in the growth due to and less focus on development of low-cost generic equivalents of specialty drugs. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global specialty pharmaceuticals market market.

On the basis of type, the global specialty pharmaceuticals market is studied across CNS, Infectious diseases, Momen’s health, Oncology, and Respiratory.

On the basis of distribution channel, the global specialty pharmaceuticals market is studied across Infectious Diseases, Physician Clinics, and Retail and specialty pharmacies.

On the basis of geography, the global specialty pharmaceuticals market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

“Accredo Health Group, Inc.: The potential growing player for the global specialty pharmaceuticals market”

The key players profiled in the global specialty pharmaceuticals market are Accredo Health Group, Inc., Avella Specialty Pharmacy, Inc., CIGNA Pharmacy Management, CVS Health Corporation, Diplomat Pharmacy, Inc., ENESI, Endo Pharmaceuticals Inc., Humana Pharmacy, Inc., Hyphens Pharma Pte Ltd., Kroger Specialty Pharmacy, Inc., McKesson Corporation, Midatech Pharma PLC, US WorldMeds, LLC, UnitedHealth Group Incorporated, and Walgreens Boots Alliance, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global specialty pharmaceuticals market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global specialty pharmaceuticals market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global specialty pharmaceuticals market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global specialty pharmaceuticals market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global specialty pharmaceuticals market.